| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |